Pacira BioSciences (PCRX) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Pacira BioSciences (NASDAQ: PCRX): 10/9/2026 – Pacira BioSciences was downgraded by Truist Financial Corporation from “buy” to “hold”. They now have a $36.50 price target on the stock, up from $31.00. 10/9/2026 – Pacira BioSciences had its price target raised by Royal Bank Of […]
21 Oct 18:56 · The Cerbat Gem